12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin
Public ClinicalTrials.gov record NCT00473525. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, Randomized, Placebo-Controlled, Parallel Group, Multiple-Dose Study To Evaluate The Efficacy, Safety, And Tolerability Of 12-Week Oral Administration Of PF-00734200 Tablets To Subjects With Type 2 Diabetes Mellitus On Stable Treatment With Metformin
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this Phase 2a study is to evaluate the efficacy, safety and tolerability, of multiple parallel doses of PF-00734200 following oral administration to adult human subjects with T2DM who currently are on a stable dose of metformin.
Study identification
- NCT ID
- NCT00473525
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 303 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- PF-00734200 10 mg QD Drug
- PF-00734200 20 mg QD Drug
- PF-00734200 5 mg QD Drug
- PF-00734200 2 mg QD Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2007
- Primary completion
- May 31, 2008
- Completion
- May 31, 2008
- Last update posted
- Jun 23, 2010
2007 – 2008
United States locations
- U.S. sites
- 64
- U.S. states
- 24
- U.S. cities
- 52
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Birmingham | Alabama | 35209 | — |
| Pfizer Investigational Site | Gilbert | Arizona | 85296 | — |
| Pfizer Investigational Site | Phoenix | Arizona | 85013 | — |
| Pfizer Investigational Site | Phoenix | Arizona | 85016 | — |
| Pfizer Investigational Site | Jonesboro | Arkansas | 72401 | — |
| Pfizer Investigational Site | Little Rock | Arkansas | 72205-6217 | — |
| Pfizer Investigational Site | Carmichael | California | 95608 | — |
| Pfizer Investigational Site | Chula Vista | California | 91911 | — |
| Pfizer Investigational Site | Fair Oaks | California | 95628 | — |
| Pfizer Investigational Site | Los Angeles | California | 90057 | — |
| Pfizer Investigational Site | National City | California | 91950 | — |
| Pfizer Investigational Site | Paramount | California | 90273 | — |
| Pfizer Investigational Site | Roseville | California | 95661 | — |
| Pfizer Investigational Site | Sacramento | California | 95825 | — |
| Pfizer Investigational Site | DeFuniak Springs | Florida | 32435 | — |
| Pfizer Investigational Site | Destin | Florida | 32541 | — |
| Pfizer Investigational Site | Jacksonville | Florida | 32216 | — |
| Pfizer Investigational Site | New Port Richey | Florida | 34652 | — |
| Pfizer Investigational Site | New Port Richey | Florida | 34653 | — |
| Pfizer Investigational Site | Palm Harbor | Florida | 34684 | — |
| Pfizer Investigational Site | West Palm Beach | Florida | 33401 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30342 | — |
| Pfizer Investigational Site | Conyers | Georgia | 30094 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60607 | — |
| Pfizer Investigational Site | Skokie | Illinois | 60076 | — |
| Pfizer Investigational Site | Skokie | Illinois | 60077 | — |
| Pfizer Investigational Site | Wheeling | Illinois | 60090 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40503 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40504 | — |
| Pfizer Investigational Site | Brockton | Massachusetts | 02301 | — |
| Pfizer Investigational Site | Worcester | Massachusetts | 01602 | — |
| Pfizer Investigational Site | Ann Arbor | Michigan | 48106 | — |
| Pfizer Investigational Site | Canton | Michigan | 48187 | — |
| Pfizer Investigational Site | Flint | Michigan | 48532 | — |
| Pfizer Investigational Site | Biloxi | Mississippi | 39531 | — |
| Pfizer Investigational Site | Picayune | Mississippi | 39466 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63141 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68114 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89119 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89128 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89148 | — |
| Pfizer Investigational Site | Trenton | New Jersey | 08611 | — |
| Pfizer Investigational Site | Cary | North Carolina | 27518 | — |
| Pfizer Investigational Site | Raleigh | North Carolina | 27609 | — |
| Pfizer Investigational Site | Raleigh | North Carolina | 27612 | — |
| Pfizer Investigational Site | Marion | Ohio | 43302 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73103 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73119 | — |
| Pfizer Investigational Site | Carnegie | Pennsylvania | 15106 | — |
| Pfizer Investigational Site | East Providence | Rhode Island | 02914 | — |
| Pfizer Investigational Site | Bartlett | Tennessee | 38134 | — |
| Pfizer Investigational Site | Collierville | Tennessee | 38017 | — |
| Pfizer Investigational Site | Kingsport | Tennessee | 37660 | — |
| Pfizer Investigational Site | Dallas | Texas | 75230 | — |
| Pfizer Investigational Site | Houston | Texas | 77023 | — |
| Pfizer Investigational Site | Houston | Texas | 77074 | — |
| Pfizer Investigational Site | Houston | Texas | 77079 | — |
| Pfizer Investigational Site | Houston | Texas | 77081 | — |
| Pfizer Investigational Site | Irving | Texas | 75039 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78229 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78237 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23225 | — |
| Pfizer Investigational Site | Virginia Beach | Virginia | 23455 | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00473525, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2010 · Synced Sep 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00473525 live on ClinicalTrials.gov.